• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸盐和钙:枸橼酸盐比值在钙性肾结石和严重结石形成患者中的重要性。

Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.

机构信息

Department of Urology, San Cecilio University Hospital, Spain.

出版信息

BJU Int. 2013 Apr;111(4):622-7. doi: 10.1111/j.1464-410X.2012.11292.x. Epub 2012 Jul 3.

DOI:10.1111/j.1464-410X.2012.11292.x
PMID:22757744
Abstract

UNLABELLED

Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.

OBJECTIVE

To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.

MATERIAL AND METHODS

A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared.

RESULTS

In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients.

CONCLUSIONS

The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.

摘要

目的

分析尿枸橼酸和尿钙/枸橼酸比值在伴有和不伴有肾结石的钙肾石症患者中的重要性。

材料和方法

对西班牙东部安达卢西亚的 115 例患者进行了横断面研究。将患者分为两组:A 组:56 例年龄 25-60 岁、无钙肾石症;B 组:59 例年龄 25-60 岁、有钙肾石症且结石形成严重。分析和比较了患者尿液中的枸橼酸盐水平和钙/枸橼酸比值及其与结石活性的关系。

结果

在 B 组中,32.2%的患者存在枸橼酸排泄减少,而 A 组中这一比例为 14.3%(P=0.02)。B 组患者的尿枸橼酸水平低于 A 组(P=0.001),钙/枸橼酸比值高于 A 组(P=0.005)。结果表明,患者尿钙/枸橼酸比值>0.25 提示严重结石形成(敏感性 89%,特异性 57%)。经线性回归分析,我们发现尿枸橼酸水平是与患者骨密度计 T 评分值变化相关的独立因素。

结论

严重结石形成患者存在枸橼酸排泄减少,与骨密度降低有关。钙/枸橼酸比值与骨吸收标志物β-交联肽呈线性相关,当比值>0.25 时,可用于评估严重结石形成的风险。

相似文献

1
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.枸橼酸盐和钙:枸橼酸盐比值在钙性肾结石和严重结石形成患者中的重要性。
BJU Int. 2013 Apr;111(4):622-7. doi: 10.1111/j.1464-410X.2012.11292.x. Epub 2012 Jul 3.
2
Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis.枸橼酸盐与钙的比例在肾钙结石和严重结石形成患者中的重要性
BJU Int. 2013 Apr;111(4):529-30. doi: 10.1111/j.1464-410X.2012.11293.x. Epub 2012 Jul 3.
3
Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.特发性钙肾结石患者严重成石活性的生化决定因素。
Urology. 2012 Jan;79(1):48-54. doi: 10.1016/j.urology.2011.07.1382. Epub 2011 Sep 9.
4
Mineral density and bone remodelling markers in patients with calcium lithiasis.钙结石患者的骨密度和骨重建标志物。
BJU Int. 2011 Dec;108(11):1903-8; discussion 1908. doi: 10.1111/j.1464-410X.2011.10167.x. Epub 2011 May 9.
5
Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.骨质疏松症和骨质减少患者血清及尿液结石形成风险因素的回顾性研究。
Urology. 2015 Apr;85(4):782-5. doi: 10.1016/j.urology.2015.01.019.
6
Association of severe calcium lithogenic activity and bone remodeling markers.严重钙结石形成活性与骨重塑标志物的关联。
Urology. 2013 Jul;82(1):16-21. doi: 10.1016/j.urology.2013.02.035. Epub 2013 Apr 16.
7
Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density.患有肾钙质结石、严重成石活性和骨密度丧失的患者的代谢-矿物质研究。
Singapore Med J. 2012 Dec;53(12):808-13.
8
Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.肾结石患者体重指数与 24 小时尿液化学定量的关系。
Urology. 2010 Jun;75(6):1289-93. doi: 10.1016/j.urology.2009.09.024.
9
Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis.钙性肾结石与骨矿物质密度。骨代谢在尿路结石形成中的重要性。
Actas Urol Esp. 2013 Jun;37(6):362-7. doi: 10.1016/j.acuro.2012.10.003. Epub 2013 Feb 12.
10
Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.饮食中补充钠治疗的低枸橼酸钙草酸钙结石患者尿结石危险因素的变化
J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.

引用本文的文献

1
Exploring the characteristics of gut microbiome in patients of Southern Fujian with hypocitraturia urolithiasis and constructing clinical diagnostic models.探索闽南地区低枸橼酸尿性尿路结石患者肠道微生物群特征并构建临床诊断模型。
Int Urol Nephrol. 2023 Aug;55(8):1917-1929. doi: 10.1007/s11255-023-03662-6. Epub 2023 Jun 9.
2
Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study.骨密度低是结石病患者症状发作的潜在风险因素,与低柠檬酸尿症有关:一项单中心回顾性队列研究。
BMC Urol. 2020 Oct 29;20(1):174. doi: 10.1186/s12894-020-00749-5.
3
Evolution of bone mineral density in patients with idiopathic hypercalciuria: a 20-year longitudinal study.
特发性高钙尿症患者骨密度的演变:一项 20 年的纵向研究。
Pediatr Nephrol. 2021 Mar;36(3):661-667. doi: 10.1007/s00467-020-04754-6. Epub 2020 Sep 26.
4
Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.创新型长效复方药物治疗远端肾小管性酸中毒患者的疗效和安全性:一项开放标签的对照试验与标准治疗比较。
Pediatr Nephrol. 2021 Jan;36(1):83-91. doi: 10.1007/s00467-020-04693-2. Epub 2020 Jul 26.
5
Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.采样时间对健康及结石形成的成人和儿童尿液结石风险指标的影响。
BMC Urol. 2018 Dec 19;18(1):116. doi: 10.1186/s12894-018-0430-8.
6
Medical and dietary interventions for preventing recurrent urinary stones in children.预防儿童复发性尿路结石的医学和饮食干预措施。
Cochrane Database Syst Rev. 2017 Nov 9;11(11):CD011252. doi: 10.1002/14651858.CD011252.pub2.
7
Development of a LC-MS/MS Method for the Simultaneous Detection of Tricarboxylic Acid Cycle Intermediates in a Range of Biological Matrices.建立一种用于同时检测多种生物基质中三羧酸循环中间体的液相色谱-串联质谱法。
J Anal Methods Chem. 2017;2017:5391832. doi: 10.1155/2017/5391832. Epub 2017 Sep 18.
8
Signification of distal urinary acidification defects in hypocitraturic patients.低枸橼酸尿症患者远端肾小管酸化功能缺陷的意义
PLoS One. 2017 May 19;12(5):e0177329. doi: 10.1371/journal.pone.0177329. eCollection 2017.
9
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.骨重塑标志物作为骨质减少-骨质疏松症患者的结石形成风险因素
Int Urol Nephrol. 2016 Nov;48(11):1777-1781. doi: 10.1007/s11255-016-1361-5. Epub 2016 Jul 4.
10
The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.在骨质减少/骨质疏松患者中,尿钙作为致石因素的重要性。
Int Urol Nephrol. 2015 Mar;47(3):445-9. doi: 10.1007/s11255-015-0918-z. Epub 2015 Feb 5.